Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2011 by Ethical Oncology Science.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Ethical Oncology Science

ClinicalTrials.gov Identifier:

NCT01283945

First received: January 25, 2011

Last updated: NA

Last verified: January 2011

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2012 (Final data collection date for primary outcome measure)